Fluoroscopic-guided right ventricular (RV) endomyocardial biopsy (EMBx) is the conventional method for obtaining myocardial samples to assess for rejection following heart transplantation. This study was designed to assess the feasibility and accuracy of guiding RV sheath and bioptome tip position using real-time three-dimensional echocardiography (RT3DE).
Introduction
Right ventricular (RV) endomyocardial biopsy (EMBx) performed via percutaneous venous access is the method of choice for obtaining myocardial samples for histological evaluation. This procedure is routine following cardiac transplantation to assess for acute rejection, particularly in the first 12 months following transplantation. 1 -3 It is also used to investigate certain cardiomyopathic processes, including acute myocarditis, infiltrative and restrictive disorders (such as amyloidosis or haemochromatosis). 3 EMBx is conventionally performed using fluoroscopic guidance to direct the bioptome tip toward the inter-ventricular septum. Inadvertent sampling from the RV free wall increases the risk of free wall perforation and subsequent cardiac tamponade. Hence it is recommended that post-transplant myocardial sampling is obtained from the inter-ventricular septum. 4, 5 Echocardiographic guidance of endomyocardial biopsies has the potential ability to overcome these limitations. 4 -12 This study sought to assess the feasibility of real-time three-dimensional echocardiographic (RT3DE) guidance of heart biopsies. The aim was to compare fluoroscopic vs. RT3DE assessment of the long sheath tip position within the RV cavity and hypothesized that RT3DE could be used to reposition the sheath tip and bioptome tip in a safe and effective manner, resulting in more accurate sampling from the inter-ventricular septum, rather than the RV free wall.
Methods

Patient population
Patients who were referred for EMBx at The Prince Charles Hospital (a cardiac transplantation centre) were prospectively enrolled in this study. These patients included both cardiac transplant recipients requiring a biopsy for surveillance or confirmation of rejection and those patients requiring a native heart biopsy to diagnose a cardiomyopathic process. Study approval was obtained from the Human Research and Ethics Committee at our institution. Written, informed consent was obtained from all patients prior to enrolment in the study.
Endomyocardial biopsy procedure
The EMBx procedure was performed in a day procedures operating theatre using the conventional technique by one of three experienced operators in heart biopsies. Ultrasound guidance (SonoSite M-Turbo, Bothwell, WA, USA) was used to help obtain jugular venous access. A 9 French jugular sheath was inserted into the right internal jugular vein, through which a 7 French long sheath was passed into the right ventricle under fluoroscopic control. Using fluoroscopic imaging, the aim was to position the tip of the long sheath against the mid to distal interventricular septum. A 5.5 French disposable bioptome (Cordis, Bridgewater, NJ, USA) was inserted through the long sheath under fluoroscopic control. Samples were then obtained from the inter-ventricular septum, with the aim to obtain at least five satisfactory myocardial specimens.
Echocardiographic technique
Echocardiographic imaging was performed in all patients in the supine position, using a Philips iE33 scanner (Andover, MA, USA). Clips were stored retrospectively. Prior to commencement of the EMBx procedure, two-dimensional transthoracic echocardiographic (2D TTE) images were obtained at baseline. The 2D TTE images were obtained using a S5-1 phased array transducer and were used to assess for the following parameters: image quality, optimal window for imaging, tricuspid valve anatomy and regurgitation and pericardial fluid. RT3DE imaging was then performed using an X3-1 matrix array transducer. The window that obtained an optimal view of the RV cavity, interventricular septum, and sheath/bioptome was utilized. Views assessed were the apical four-chamber view, parasternal RV inflow view, and the subcostal four-chamber window. The 3D settings were then adjusted to provide a satisfactory working image with a sector size of 55 degrees by 29 degrees and typical frame rates of 18 to 23 Hz. Following completion of the procedure, a limited 2D TTE was performed to assess for any complications, such as tricuspid valve damage, worsening tricuspid regurgitation, myocardial rupture, or a pericardial effusion.
Image interpretation
Following fluoroscopic positioning of the long sheath tip to the mid to distal septal position, RT3DE imaging was used to assess the long sheath tip position. Data points collected were: overall 3D echocardiographic image quality (not obtainable, sub-optimal, good), long sheath tip position (directed toward the basal -mid-distal inter-ventricular septum, RV apex, basal-mid -distal RV free wall), clarity of bioptome tip image during the biopsy (not obtainable, sub-optimal, good), and position of the bioptome sample site (basal-mid -distal interventricular septum, RV apex, basal-mid-distal RV free wall). This information was determined by the proceduralist at the time of the procedure.
Other parameters assessed were: number of passes made with the bioptome, number of myocardial samples obtained, radiation dosage (as a function of milliGrays delivered by the image intensifier), fluoroscopic time, presence or absence of pacemaker or implantable defibrillator leads and the detection of any complications. These were compared with 40 randomly selected non-study biopsy procedures. These non-study patients consisted of heart transplant recipients undergoing surveillance heart biopsies that were performed by the same operators just prior to or immediately after the study period. However, no native heart biopsy patients were included in the nonstudy group. Other than using RT3DE, the procedures were identical.
Procedure time
The procedure time was measured in minutes and seconds, commencing from the satisfactory placement of the long sheath in the RV using fluoroscopic control and ending at the time when the last myocardial sample was obtained. These timing parameters were chosen, rather than to time the whole procedure, to remove non-study confounding variables such as patient preparation, obtaining venous access and instrument organization and preparation. Consequently, the time recorded directly assessed whether the addition of RT3DE guidance for heart biopsies either increased or decreased the actual procedure time, compared with fluoroscopic guidance alone.
Statistical analysis
Continuous variables were expressed as mean + 1 standard deviation (SD) and range for absolute values. The categorical variables were presented as a number and percentage. Two sample t-tests were used to compare continuous variables. A P-value of ,0.05 was defined as statistically significant. Kendall's tau rank correlation coefficient was used to compare the position of the sheath tip on fluoroscopy to that determined by RT3DE. A perfect agreement between the two variables would provide a Kendall tau coefficient of 1.0. Statistical analysis was performed using MedCalc version 10.0 (Mariakerke, Belgium).
Results
Forty procedures were performed in 21 patients. Mean age was 50.6 + 14.8 years (range 18 -76 years). There were 16 males and 5 females. Five patients had native heart biopsies and 16 patients had biopsies performed following cardiac transplantation. The internal jugular approach was used in all patients. Only one patient was excluded from the study due to inadequate echocardiographic images at baseline. A total of 243 myocardial samples were obtained from 306 passes. Adequate myocardial samples were obtained from all patients. The mean number of passes made was 7.8 + 3.4 (range [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] and the mean number of samples obtained was 6.2 + 2.4 (range 5 -14) . There were no complications detected as a result of any of the procedures, either in the study or the non-study group.
A standard or modified apical four-chamber view provided the best imaging window and best anatomical landmarks in all cases. Overall RT3DE image quality was classified as good in 32 cases (80%), sub-optimal in 7 cases (17%), and uninterpretable in 1 case (3%). Sheath tip visualization with RT3DE upon initial imaging was good in 31 patients, sub-optimal in 6 patients, and not obtainable in 3 patients.
Positioning of the long sheath under fluoroscopic control resulted in mid septal alignment in 7 patients (18%), distal septal alignment in 30 patients (75%), and apical alignment in 3 patients (7%). Following imaging with RT3DE, adjustment of long sheath alignment was necessary in 18 patients (46%), to optimize the site of myocardial sampling. This was due to the sheath being aligned to the apex (n ¼ 9), distal free wall (n ¼ 5), or mid free wall (n ¼ 4) as shown in Figures 1 and 2 . Using the distal interventricular septum as the ideal reference point, the sheath tip was one segment removed from the reference in nine patients (24%), two segments removed from the reference in five patients (13%), and three segments removed from the reference in four patients (10%). The Kendall tau coefficient for comparing sheath tip position on RT3DE compared with fluoroscopy was 0.18.
Fluoroscopy was then used to guide bioptome placement and RT3DE was performed to assess bioptome tip location. Bioptome tip visualization within the right ventricle using RT3DE imaging was good in 255 passes (83%), sub-optimal in 39 passes (13%), and not obtainable in 12 passes (4%). Locations were identified as mid interventricular septum (87 passes, 28%), distal interventricular septum (107 passes, 35%), apex (57 passes, 19%), distal free wall (29 passes, 10%), mid free wall (22 passes, 7%), or basal free wall (4 pass, 1%). Note, the basal free wall (three passes) and mid free wall (two passes) were deliberately sampled, to obtain pathological RV free wall tissue. Hence, in 35% of passes, the results of RT3DE prompted repositioning of the bioptome location in an attempt to improve the myocardial sampling site.
The bioptome tip position during myocardial sampling in all cases is represented in Figure 3 . Note, these data represent the total number of passes made with the bioptome and its position within the right ventricle. It does not reflect the actual number of samples taken from each particular segment. Figure 4A shows incorrect sheath tip alignment, being angled toward the RV free wall. Figure 4B is an example of correct sheath tip alignment, being orientated toward to distal interventricular septum. Figure 4C shows incorrect bioptome tip sampling site at the distal RV free wall. Figure 4D demonstrates satisfactory bioptome sampling site at the distal inter-ventricular septum. Figure 5 shows deliberate sampling from a thickened RV free wall in a patient where the histology from the EMBx revealed cardiac lymphoma.
Supplementary data online, Video 1 shows incorrect bioptome position at the distal RV free wall.
Supplementary data online, Video 2 show correct sampling site at the mid interventricular septum.
Supplementary data online, Video 3 shows correct sampling site at the distal interventricular septum.
Discussion
The results of this study demonstrate that it is feasible to perform RT3DE guidance in the majority of patients undergoing an EMBx. The information obtained from an echocardiogram necessitated the repositioning of the long sheath tip, which had been positioned under fluoroscopic control, in 46% of the cases. During the actual sampling of the myocardium, RT3DE guidance resulted in repositioning of the actual bioptome in 35% of passes.
EMBx is an invasive procedure that is performed in selected patients, to assess for rejection following heart transplantation, or to obtain myocardial histology for diagnostic purposes. While it is generally a safe procedure, its invasive nature does pose the risk of potentially significant complications. A large prospective study by Deckers et al. 13 reported an overall complication rate of 6% (2.7% from sheath insertion and 3.3% during the biopsy procedure). The mortality associated with the procedure is usually Figure 1 Bar graph representing sheath tip position as visualized using RT3DE as a function of initial positioning using fluoroscopy.
Comparison of fluoroscopic versus RT3DE guidance of EMBx due to cardiac tamponade caused by RV perforation. The incidence of cardiac perforation/tamponade has been variably reported between 0.14 14 and 0.5%. 13 Another structural complication of EMBx is traumatic tricuspid valve disease. Tricuspid regurgitation is the most common valvular disorder post cardiac transplant 15 and is often due to repeated trauma from endomyocardial biopsies. However, the use of a long sheath (as utilized in this study) may reduce the likelihood of this occurring. Endomyocardial biopsies are performed using fluoroscopic visualization of long sheath insertion and manipulation of the bioptome tip. The advantages of fluoroscopy include high temporal resolution and the ability to always visualize the tip of the bioptome. However, fluoroscopic guidance also has its limitations. The inability to directly visualize anatomic/spatial location of the bioptome tip within the right ventricle is a major limitation. It is a twodimensional technique that relies on anatomical assumptions to correlate the tip position within the right ventricle. This limitation may be confounded in the post-transplant patient where there may be a degree of clockwise rotation (when viewed from the caudal aspect) of the heart in the post-operative state. 16 Availability of an image intensifier and space for the X-ray equipment are other potential limitations. As a result of these limitations of fluoroscopic guidance, echocardiography has been utilized as an alternative or complementary form of imaging to guide endomyocardial biopsies. Transoesophageal echocardiography has been reported as a safe and effective form of guidance for heart biopsies. 17 However, its invasive nature, inherent risks, and requirement for sedation preclude this from being used as a routine form of echocardiographic guidance during heart biopsies. 2D TTE has also been evaluated in guiding endomyocardial biopsies. In one of the initial reports using 2D TTE, Williams et al. 18 reported that it was a safe and effective technique in guiding the bioptome in a series of 163 procedures in 83 patients. Pierard et al. 19 at the same time also reported a 100% success rate of identifying the site of sampling using 2D TTE during 22 procedures in 18 patients. Over the next 15 years, numerous original articles and case reports were published demonstrating utility in using 2D TTE to guide endomyocardial biopsies. 7 -9,11,16,20 -23 A more recent development in echocardiography has been the advent of 3D TTE made possible by the development of fully sampled, matrix array transducers. 24 While numerous 3D TTE imaging modalities are available, endomyocardial biopsies can be guided using real-time (or 'live') 3D TTE. This form of imaging provides a 3D sector of data (typically 608 in width and 308 in depth) that can be acquired, viewed, and manipulated in real time during the biopsy procedure. 3D TTE has also been shown to have utility in guiding endomyocardial biopsies. 5, 10, 12, 25 In the current study, it was possible to adequately visualize the right heart structures with real-time 3D TTE in the majority of patients. This initial premise is important to establish because the environment faced by the sonographer during an EMBx does not lend itself to easy imaging. Factors present that can potentially hinder satisfactory ultrasound images include: sub-optimal patient positioning (supine), sub-optimal bed height (table positioned to suit the proceduralist), close proximity of the image intensifier, limited access to acoustic windows (having to scan under a sterile drape), and sub-optimal lighting conditions. However, despite these potential limitations, it was possible for the sonographers in this study to obtain good quality images in 80% of cases with the apical four chamber (or modified view) providing the best imaging.
Sheath tip location and orientation within the right ventricle was one of the main variables in this study. This tip can be easily visualized in all cases using fluoroscopy. The addition of RT3DE enabled clear visualization of this tip in 80% of cases. In only 7% of cases, it was not possible to identify long sheath tip within the right ventricle using RT3DE. Successful EMBx is dependent upon satisfactory sheath positioning as malalignment will result in direction of the bioptome tip to an incorrect location within the right ventricle. In those cases where the tip could not be seen or only sub-optimally imaged, the passage of the bioptome to the end of the sheath, or the injection of a small amount of agitated saline, usually resulted in the identification of sheath tip position.
Following insertion of the bioptome, it was possible to visualize the tip in the majority of cases (96%). This is most likely due to the ability of RT3DE to provide depth perception within the field of view. Scanning a dynamic process such as bioptome manipulation using conventional single plane TTE can be difficult due to the relatively rapid motion of the bioptome through a three-dimensional structure. Consequently, at any one time, the shaft may be visualized at a particular point but not necessarily the bioptome tip. The key point of imaging during this procedure is to assess the bioptome tip in relation to the endocardium and which segment will be sampled. By providing a 308 depth of field (with the added ability to move forward or backward another 308, proving an almost instantaneous 908 sector-using the back-centre-front modality), RT3DE increases the likelihood of visualization of the tip within the right ventricle.
After appropriate fluoroscopic placement of the long sheath, assessment with RT3DE imaging resulted in the necessity to reposition the sheath tip location in 46% of patients. In this study, sheath repositioning was necessary due to initial alignment toward the RV apex, distal RV free wall, or mid RV free wall. None of these positions are routinely recommended as appropriate sampling sites. While RT3DE-guided heart biopsy studies have been previously published, this work is unique in that it also assessed initial long sheath tip position in the right ventricle with RT3DE, not just the bioptome tip. There is a trend toward placing a long sheath across the tricuspid valve during heart biopsies, as this method reduces the number of times instruments pass across the tricuspid valve. This is designed to reduce the incidence of valve damage. Following RT3DE-guided repositioning of the long sheath into a more suitable orientation, it was still necessary to reposition the bioptome tip using RT3DE in 35% of cases. A similar degree of discrepancy between fluoroscopic-and TTE-guided sampling has been previously described. 10, 12, 26 This was most likely due to a relatively rigid metallic bioptome shaft re-orientating a more flexible plastic long sheath. The stiffer bioptome shaft had a tendency to straighten the manufactured angulation of the long sheath, hence the relatively high number of bioptome tips orientated toward the apex rather than the interventricular septum. Consequently, the results of this study indicate that the presence of satisfactory Comparison of fluoroscopic versus RT3DE guidance of EMBx long sheath orientation does not necessarily result in obtaining anatomically correct sampling sites. As such, the proceduralist needs to be aware of this potential complication. Compared with non-study patients, there was no significant difference in either fluoroscopic time or radiation dosage and there were no complications in either group. This suggests that the echocardiographic approach to EMBx is clinically feasible and unlikely to adversely impact on the workflow within a procedural laboratory. The lack of complications suggest that it a safe procedure. It could also be argued that the presence of an echo machine to instantly assess for any complications could even improve the safety profile of EMBx.
While no procedure-related complications occurred during this study, the ability to provide instant echocardiographic assessment for this has the potential to rapidly diagnose cardiac perforation or other associated structural complications. Tricuspid valve damage can occur following repeated passing of instruments through the right heart or due to inadvertent sampling of the tricuspid valve apparatus as opposed to the myocardium. 27, 28 By tracking sheath and bioptome passage through the right atrium, tricuspid valve, and into the appropriate region of the right ventricle, RT3DE also has the ability to reduce the likelihood of sampling the tricuspid valve region (particularly the sub-valvular apparatus) and detect accidental passage of the sheath or bioptome into the coronary sinus as opposed to the right ventricle.
There are numerous potential practical benefits of RT3DE guidance for endomyocardial biopsies. First, the ability to perform a biopsy using echocardiography alone enhances the flexibility of where the actual procedure could be performed. While in this study both an image intensifier and 3D TTE were utilized, familiarity with this technique may result in TTE only being used as guidance for the procedure. Providing TTE can be used to determine guidewire positioning into the right heart (which is usually the case with a jugular venous approach), then there is potential for RV biopsies to be performed without fluoroscopy and using TTE alone. Requirement for an echo machine alone may result in biopsies being performed in the coronary care unit or the intensive care unit without having to transfer a potentially unstable patient to a cardiac catheter laboratory or operating theatre. Additionally, echocardiographic-guided biopsies reduce ionizing radiation exposure to the operator, assisting staff, and the patients, whom frequently are exposed due to the necessity for recurrent procedures. This would be particularly relevant to the paediatric and younger adult population undergoing this procedure.
Study limitations
This study was not designed as a randomized trial to compare two different forms of imaging to perform endomyocardial biopsies. While there is no gold standard to guide bioptome positioning, fluoroscopy is considered the conventional imaging technique to assist in this procedure. However, our results, amongst others, suggest that echocardiography may provide incremental information over that provided by fluoroscopy alone. Also, this study did not directly compare the merits of 3D TTE over conventional 2D TTE. It is unlikely that 3D TTE confers a benefit over standard 2D TTE in the detection of complications following an EMBx. 2D TTE is also likely to be just as useful in imaging some parts of the bioptome shaft. However, the key is to identify the tip of the bioptome and this is where the depth perception provided by RT3DE is likely to provide advantage over 2D TTE. Also, as this was a new biopsy technique, both for the proceduralist and the sonographer, there would have been a learning curve associated with the RT3DE-guided technique. The potential impact of this was not measured. Finally, one of the three single experienced operators interpreted the RT3DE images during the procedure. Assessing for inter-observer variability with offline image analysis postprocedure may have strengthened the study.
Conclusion
The results of this study indicate that RT3DE guidance for EMBx is both a feasible and safe technique. Both the sheath tip and the bioptome tip could be adequately visualized in the majority of patients using RT3DE. In nearly half (46%) the patients with assumed correct placement of the sheath using fluoroscopy, the sheath was repositioned following data obtained from RT3DE due to suboptimal sheath orientation. In 35% of cases, the bioptome tip had to be repositioned just prior to sampling as imaging using RT3DE indicated the biopsy would be obtained from an unsatisfactory site.
Fully sampled matrix array transducers offer numerous imaging benefits when used as real-time 3D TTE devices. The most significant benefit is the ability to offer a volume of imaging data with depth perception, in real time with clinically useful frame rates. Additional benefits include the ability to track the sheath and bioptome through the right heart structures and to be able to rapidly assess for any procedural complications. Practical advantages of echocardiographically guided biopsies include increasing the potential locations for the actual procedure (hence reducing patient transfer around hospitals) and decreasing the staff and patient exposure to ionizing radiation. RT3DE guidance for heart biopsies is likely to become an increasingly accepted technique and in our institution, it is now considered the imaging modality of choice for endomyocardial biopsies.
Supplementary data
Supplementary data are available at European Journal of Echocardiography online.
